BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 14, 2004
View Archived Issues
Activity of fidarestat in diabetic neuropathy evaluated in mice and humans
Read More
Schering AG names new derma company Intendis
Read More
Bonefos accepted for priority review
Read More
Oscient launches Factive for lower respiratory tract infections
Read More
Roche and Structural GenomiX form antiviral alliance
Read More
New FAAH inhibitors and their use in pain and other disorders
Read More
Aventis presents novel PTP inhibitors and their use
Read More
Novel GPa inhibitors prepared and tested by Aventis researchers
Read More
New gamma-secretase inhibitors designed by Sanofi-Synthelabo team
Read More
Pfizer claims new 5-HT7 receptor modulators for depression, anxiety, etc.
Read More
New alpha2, alpha3 and/or alpha5-selective GABA-A receptor ligands claimed by Merck
Read More
Novel 11beta-HSD-1 inhibitors in early development at Novartis
Read More
New PYY analogues and their use in body weight disorders
Read More
Promising p38alpha inhibitor against the progression of rheumatoid arthritis
Read More
Orally active PDE4 inhibitor for the treatment of inflammatory respiratory diseases
Read More
Antiobesity treatment with melanin-concentrating hormone receptor-1 antagonist
Read More
Enrollment completed in phase III anidulafungin study
Read More
Multikine lowers cholesterol in clinical studies
Read More
H3 Pharma and DSM sign manufacturing agreement for SC-1
Read More
New dosage strengths of Avandamet approved in E.U.
Read More
IR-103 enters first clinical testing
Read More
Positive phase IIb results for harkoseride in epilepsy
Read More
Vivus initiates phase III study of Alista
Read More
Eurand to develop modified-release lercanidipine for Recordati
Read More
TheraQuest Biosciences discovers analgesic synergy with narcotics
Read More
Strakan and ProSkelia complete merger, renamed ProStrakan
Read More
Rivastigmine reported to slow cognitive decline in AD regardless of disease severity
Read More
Clinical trials assess the effects of magnesium sulfate in asthma and COPD
Read More
Tobacco smoke and immunosuppression in lung transplantation
Read More
Coating medical devices with key protein to prevent infection
Read More
FDA advisory committee recommends further data for Exanta approval
Read More
Aminoguanidine, ALT-711 renoprotective in hyperlipidemia/diabetes model
Read More